Detalles de la búsqueda
1.
Annals of the Rheumatic Diseases collection on pregnancy 2018-2023: observational data-driven knowledge.
Ann Rheum Dis
; 2024 Feb 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38331590
2.
Evaluation of discontinuation for adverse events of JAK inhibitors and bDMARDs in an international collaboration of rheumatoid arthritis registers (the 'JAK-pot' study).
Ann Rheum Dis
; 83(4): 421-428, 2024 Mar 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38071508
3.
Potential impact of European Medicines Agency measures to minimise risk of serious side effects on JAKi prescribing and utilisation in the UK.
Rheumatology (Oxford)
; 2024 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38748995
4.
Socioeconomic deprivation is associated with reduced response and lower treatment persistence with TNF inhibitors in rheumatoid arthritis.
Rheumatology (Oxford)
; 63(3): 648-656, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37267152
5.
A proteomics study of rheumatoid arthritis patients on etanercept identifies putative biomarkers associated with clinical outcome measures.
Rheumatology (Oxford)
; 63(4): 1015-1021, 2024 Apr 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37389432
6.
Factors facilitating and hindering South Asian immigrant adults from engaging in exercise and physical activity - a qualitative systematic review.
BMC Public Health
; 24(1): 1342, 2024 May 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38762730
7.
Towards molecular-pathology informed clinical trials in childhood arthritis to achieve precision medicine in juvenile idiopathic arthritis.
Ann Rheum Dis
; 82(4): 449-456, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36600186
8.
Pre-treatment calprotectin (MRP8/14) provides no added value to testing CRP alone in terms of predicting response to TNF inhibitors in rheumatoid arthritis in a post hoc analysis.
Ann Rheum Dis
; 82(5): 611-620, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36810200
9.
Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis.
Ann Rheum Dis
; 82(1): 95-106, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36368906
10.
Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis.
Ann Rheum Dis
; 82(1): 81-94, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36410794
11.
2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases.
Ann Rheum Dis
; 82(6): 742-753, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36328476
12.
After JAK inhibitor failure: to cycle or to switch, that is the question - data from the JAK-pot collaboration of registries.
Ann Rheum Dis
; 82(2): 175-181, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36100351
13.
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update.
Ann Rheum Dis
; 82(1): 3-18, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36357155
14.
Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update.
Ann Rheum Dis
; 82(6): 773-787, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35953263
15.
Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries.
Ann Rheum Dis
; 82(5): 698-709, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36787993
16.
The impact of psoriasis on wellbeing and clinical outcomes in juvenile psoriatic arthritis.
Rheumatology (Oxford)
; 2023 Jul 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-37467079
17.
The incidence and prevalence of Juvenile Idiopathic Arthritis differs between ethnic groups in England.
Rheumatology (Oxford)
; 2023 Dec 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38135502
18.
Evaluation of serious infections, including Mycobacterium tuberculosis, during treatment with biologic disease-modifying antirheumatic drugs: does line of therapy matter?
Rheumatology (Oxford)
; 2023 Sep 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37758229
19.
Continuing specialist care into adulthood in young people with juvenile idiopathic arthritis: a retrospective cohort study using electronic health records in England.
Rheumatology (Oxford)
; 62(5): 1936-1943, 2023 05 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36135794
20.
Etanercept originator versus etanercept biosimilar for the treatment of rheumatoid arthritis as a first biologic: results from the BSRBR-RA.
Rheumatology (Oxford)
; 62(12): 3849-3857, 2023 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36943379